TB-500 is a synthetic peptide derived from thymosin beta-4, centered on the actin-binding domain of that naturally occurring protein. This overview covers the standalone compound as a research tool, complementing the existing thymosin-beta-4 overview and situating TB-500 within actin-regulation and tissue-repair research.
What it represents
By focusing on the actin-binding region of thymosin beta-4, TB-500 serves as a compact probe for studying actin regulation and cell migration in model systems. Rather than reproducing the entire parent protein, it captures the functional core most relevant to cytoskeletal research. Its mechanism of action details this actin-sequestering activity.
Relationship to thymosin beta-4
Thymosin beta-4 is a widely distributed regulator of the actin cytoskeleton, and TB-500 is designed to represent its principal active region. Studying the fragment lets researchers isolate actin-related effects from other functions of the full-length protein, a common strategy when investigating a specific domain.
Why studied standalone
While often paired with BPC-157 in combination research (see combination research), the standalone form isolates its own contribution to endpoints like angiogenesis and cell migration. Examining it alone clarifies which observed effects belong to TB-500 rather than to a combination.
Common research endpoints
Because actin dynamics underlie motility and remodeling, model-system studies frequently look at migration, wound-closure assays, and angiogenic readouts, all of which connect back to the peptide's cytoskeletal role.
Research context
Batch quality is documented via TB-500 purity testing, and reliable results depend on well-characterized material.
Terminology and reagent identity
TB-500 and full-length thymosin beta-4 are sometimes discussed as though they were synonyms, but experimental reports should identify the exact sequence and molecular form used. A fragment can preserve an actin-related motif without reproducing every interaction of the forty-three-residue parent peptide. This distinction affects molecular weight, purity analysis, stability, and the conclusions that can be drawn from a model. Researchers should therefore verify the supplier specification and analytical documentation before comparing results across publications or batches. Clear nomenclature prevents observations from a fragment reagent from being automatically attributed to intact endogenous thymosin beta-4. Interpretation should remain proportional to the model. Faster closure of a scratch assay, for example, can reflect migration, proliferation, altered adhesion, or a combination of these processes. Parallel proliferation controls, live-cell imaging, and actin-organization measurements help identify which component changed. Such controls make a standalone experiment more informative before the peptide is compared with other research compounds.
Product page: TB-500 research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.